Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Joseph OConnell Insider Profile
4 Followers
Daniel Joseph OConnell, President & CEO, Director at Acumen Pharmaceuticals, holds 502.49K shares in Acumen Pharmaceuticals (Ticker: ABOS).
Daniel Joseph OConnell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel Joseph OConnell's holdings
Insider Roles
President & CEO, Director
Roles that Daniel Joseph OConnell holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Joseph OConnell
Daniel Joseph OConnell's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Joseph OConnell's performance on stock
You May Also Like
Daniel Joseph OConnell insider profile FAQ
What is the percentage of profitable transactions made by Daniel Joseph OConnell?
The percentage of profitable transactions made by Daniel Joseph OConnell is ―.
What is the average return per transaction made by Daniel Joseph OConnell?
The average return per transaction made by Daniel Joseph OConnell is ―.
What stocks does Daniel Joseph OConnell hold?
Daniel Joseph OConnell holds: ABOS stocks.
What was Daniel Joseph OConnell’s latest transaction?
Daniel Joseph OConnell latest transaction was an Uninformative Sell of $52.74K.
What was Daniel Joseph OConnell's most profitable transaction?
Daniel Joseph OConnell’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Joseph OConnell's role in Acumen Pharmaceuticals?
Daniel Joseph OConnell's role in Acumen Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.